Skip to main content
ADMISSIONS/ROLLING
JOIN THE STUDENT DISCORD
CASE STUDY · YRI FELLOW
Atharv Ved
Atharv VedGENOMICS & PRECISION MEDICINE

Built a CRISPR target prediction pipeline for heart disease, accepted at two IEEE conferences

Atharv developed a computational framework for predicting safe, high-specificity CRISPR-Cas9 guide RNAs targeting the cardiac remodelling genes MYH7, ACTC1, TNNT2 and NPPA. He retrieved sequences from NCBI GenBank, scanned for SpCas9 PAM sites using Biopython and scored candidate guides through BLAST-based off-target profiling with mismatch heatmapping and specificity scoring. All three tested guides hit roughly 100% editing efficiency, but only gRNA2 targeting MYH7 combined that with the lowest off-target burden.

FIELDGenomics & Precision Medicine
RESULTAccepted at IEEE ICPCSN 2026 and IEEE ISASF 2026
VENUEIEEE ICPCSN 2026 · IEEE ISASF 2026, 2026
Atharv Ved
Atharv Ved, YRI FellowIEEE ICPCSN
BEFORE THE FELLOWSHIP

A high school student self-taught in Python and bioinformatics, interested in genomics but with no prior peer-reviewed research experience.

AFTER

Built a CRISPR target prediction pipeline for cardiac disease and was accepted at two IEEE international conferences as a high schooler.

THE LEDGER
01Accepted at IEEE ISASF 2026 in Sydney, Australia
02Accepted for a 15-minute oral presentation at IEEE ICPCSN 2026 in Salem, May 6 to 8, 2026
03Analyzed 4 cardiac remodelling genes and evaluated 3 candidate guide RNAs
04Identified gRNA2 targeting MYH7 as the strongest clinical candidate
05Mapped the top 20 off-target sites per guide for safety screening
NEXT CASE STUDYRyan Vo, Accepted at IEEE ICIEA26

Every case study starts with one application.

ROLLING ADMISSIONS · SEATS LIMITED · NOW REVIEWING